$13.5 Billion Opportunity Analysis on the Global Aortic Valve Replacement Devices Market (2018-2025)
Aug 31, 2018, 18:45 ET
DUBLIN, Aug. 31, 2018 /PRNewswire/ --
The "Aortic Valve Replacement Devices Market Size, Share And Trends Analysis Report By Surgery (Open, Minimally Invasive), By Product (Transcatheter Aortic Valve, Sutureless Valve), By End-user, And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.
The global aortic valve replacement market size is expected to reach USD 13.49 billion by 2025, registering a CAGR of 11.1% during the forecast period.
Technological advancements in aortic valves and favorable reimbursement policies are boosting the growth of the market. Rising demand for minimally invasive surgeries is also triggering the growth of the market.
Widening base of geriatric population is one of the key growth stimulants. As per data published by Medicare and Medicaid services, the number of aortic stenosis patients over 65 years of age is constantly increasing in the U.S. Thus, rising incidence of aortic stenosis coupled with improving treatment rates is expected to bolster the growth of the market over the forecast period.
In addition, growing preference for minimally invasive surgeries is escalating the growth of the market. These procedures cause lesser trauma to patient along with better outcomes and facilitate faster recovery than conventional open-heart surgeries. MIS requires relatively lesser number of hospital stays and is hence economically more viable than conventional invasive surgeries.
Favorable reimbursement policies are one of the crucial factors anticipated to drive the market in the near future. Centers for Medicare & Medicaid Services (CMS) announced that it would provide coverage for TAVR under the Medicare National Coverage Determination policy.
Moreover, increasing number of clinical studies undertaken by key players for extending interventional scope, analyzing safety of devices, and assessing subsequent treatment alternatives is also working in favor of the market. However, product recalls due to safety concerns are projected to inhibit the growth of the market.
Key Findings
- Minimally invasive surgeries emerged as the leading surgery type owing to various advantages associated with them, such as limited trauma, quicker recovery, and cost-effectiveness
- The transcatheter valve segment accounted for the largest revenue share in 2017 due to rising number of clinical studies for expanding their applications
- In terms of end users, hospitals were the dominant revenue contributor in 2017 and ambulatory surgery centers (ASCs) are expected to exhibit remarkable CAGR over the forecast period
- North America emerged as the largest regional market with a revenue share of 41.9% in 2017 and Asia Pacific is anticipated to post the highest CAGR over the forecast period
- The market is highly fragmented in nature. Some of the prominent companies operating in the market are Edwards Lifesciences Corporation, Boston Scientific Corporation, St. Jude Medical, CryoLife, Medtronic, and LivoNova
Key Topics Covered
Chapter 1 Research Methodology
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 Internal database
1.2 Primary Research:
1.2.1 List of primary sources include:
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Market Variables, Trends& Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.2.1 Rising prevalence of valvular diseases
3.2.2 Increasing preference for minimally invasive surgeries
3.2.3 Favorable reimbursements
3.2.4 Initiatives for creating awareness of valve replacement
3.3 Market Restraint Analysis
3.3.1 Product recalls owing to the safety concern
3.4 Penetration & Growth Prospect Mapping
3.5 Aortic Valve Replacement Devices Market - SWOT Analysis, by Factor (Political & Legal, Economic & Technological)
3.6 Industry Analysis - Porter's
3.7 Product Distributors
3.8 Product Pipeline (Clinical Trials)
3.9 Company Market Share Analysis
Chapter 4 Aortic Valve Replacement Devices Market: Surgery Type Estimates & Trend Analysis
4.1 Aortic Valve Replacement Devices Market: Surgery Type Movement Analysis
4.2 Open Surgery
4.2.1 Open surgery market estimates and forecasts, 2014 - 2025 (USD Million)
4.3 Minimally Invasive Surgery
4.3.1 Minimally invasive surgery market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 5 Aortic Valve Replacement Devices Market: Product Type Estimates & Trend Analysis
5.1 Aortic Valve Replacement Devices Market: Product Type Movement Analysis
5.2 Transcatheter Aortic Valve
5.2.1 Transcatheter aortic valve market estimates and forecasts, 2014 - 2025 (USD Million)
5.3 Sutureless Aortic Valve Replacement (SUAVR)
5.3.1 Sutureless aortic valve replacement devices market estimates and forecasts, 2014 - 2025 (USD Million)
5.4 Others
5.4.1 Others market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 6 Aortic Valve Replacement Devices Market: End User Estimates & Trend Analysis
6.1 Aortic Valve Replacement Devices Market: End User Movement Analysis
6.2 Hospitals
6.2.1 Hospitals market estimates and forecasts, 2014 - 2025 (USD Million)
6.3 Ambulatory Surgery Centers
6.3.1 Ambulatory surgery centers market estimates and forecasts, 2014 - 2025 (USD Million)
6.4 Others
6.4.1 Others market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 7 Regional Estimates & Trend Analysis, by surgery, Product Type & End User
Chapter 8 Competitive Landscape - Company Profiles
- Boston Scientific Corporation
- Cryolife, Inc.
- Edward Lifesciences Corporation
- LivaNova PLC. (Sorin Group)
- Medtronic
- St. Jude Medical (Abbott)
- Symetis SA
For more information about this report visit https://www.researchandmarkets.com/research/qb3xtx/13_5_billion?w=5
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
